These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38476625)

  • 1. Correlations of m
    Li X; Ding Z; Tong Y
    Int J Gen Med; 2024; 17():775-790. PubMed ID: 38476625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma.
    Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma.
    Li S; Ran MY; Qiao H
    Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of m6A RNA Methylation-Related lncRNAs in the Prognosis and Tumor Immune Microenvironment of Papillary Thyroid Carcinoma.
    Wang W; Shen C; Zhao Y; Sun B; Qiu X; Yin S; Chen J; Li X
    Front Cell Dev Biol; 2021; 9():719820. PubMed ID: 35047491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients.
    Huang X; Wang HF; Huang S
    Front Genet; 2022; 13():906880. PubMed ID: 36061188
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma.
    Lin W; Tan ZY; Fang XC
    SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.
    Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ
    Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of m
    Wang X; Fu X; Zhang J; Xiong C; Zhang S; Lv Y
    Cancer Cell Int; 2020; 20():203. PubMed ID: 32514248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer.
    Xia M; Wang S; Wang L; Mei Y; Tu Y; Gao L
    Front Endocrinol (Lausanne); 2023; 14():1062317. PubMed ID: 37025405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Ferroptosis-Related Long Non-Coding RNA Risk Model Predicts the Prognosis of Patients With Papillary Thyroid Cancer.
    Zhao JY; Yao JM; Zhang XZ; Wang KL; Jiang S; Guo SY; Sheng QQ; Liao L; Dong JJ
    World J Oncol; 2024 Aug; 15(4):648-661. PubMed ID: 38993258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a novel signature based on the m
    Li H; Lin D; Wang X; Feng Z; Zhang J; Wang K
    Front Genet; 2022; 13():894080. PubMed ID: 36313417
    [No Abstract]   [Full Text] [Related]  

  • 15. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
    Wang L; Yao B; Yang J; Tian Z; He J
    BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature.
    You X; Yang S; Sui J; Wu W; Liu T; Xu S; Cheng Y; Kong X; Liang G; Yao Y
    Cancer Manag Res; 2018; 10():4297-4310. PubMed ID: 30349364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of m
    Wu X; Wang S; Wu X; Chen Q; Cheng J; Qi Z
    J Cancer; 2024; 15(7):2045-2065. PubMed ID: 38434979
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
    Liu Y; Wang T; Fang Z; Kong J; Liu J
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs.
    Zhang L; Tang X; Wan J; Zhang X; Zheng T; Lin Z; Liu T
    Front Mol Biosci; 2021; 8():715764. PubMed ID: 34733885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.